DalsnaFinance

BioLineRx shares rise 4% on first patient dosed in cancer trial

Markets Investing.com By Investing.com 27 May 2026 11:44 1 min read
BioLineRx shares rise 4% on first patient dosed in cancer trial

BioLineRx shares rise 4% on first patient dosed in cancer trial

BioLineRx shares rise 4% on first patient dosed in cancer trial

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.